TGFB1 and diabetic kidney disease: Our recent finding that mice overexpressing human latent TGF-β1 are protected from the development of streptozotocin-induced T1DN fully supports this clinical notion 15, and demonstrates a diverse role between latent versus active TGF-β1 in the pathogenesis of diabetic kidney disease 6, 7.